Get Actionable Data Faster Using BioMAP® for Lead Prioritization
Lead optimization is expensive and time consuming, requiring early and efficient evaluation of both efficacy and toxicity related effects. The BioMAP Phenotypic Screening Platform that utilizes clinically relevant human primary cell-based disease models in a powerful tool that integrates the evaluation of safety and efficacy into a single, in vitro
assay with demonstrated clinical relevancy, ensuring that only the top-tier candidates progress through your pipeline.
The BioMAP approach can help triage compounds with the highest efficacious impact and lowest risk for adverse concerns, allowing the prioritization of agents with the greatest potential for success.
Request a Quote